Home/Filings/4/0001179110-12-014130
4//SEC Filing

SYNTA PHARMACEUTICALS CORP 4

Accession 0001179110-12-014130

$MDGLCIK 0001157601operating

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 4:18 PM ET

Size

5.1 KB

Accession

0001179110-12-014130

Insider Transaction Report

Form 4
Period: 2012-09-13
Vukovic Vojo
SVP, Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2012-09-13+25,00025,000 total
    Exercise: $8.05Exp: 2022-09-13Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the shares on September 13, 2013 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.

Issuer

SYNTA PHARMACEUTICALS CORP

CIK 0001157601

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001157601

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 4:18 PM ET
Size
5.1 KB